Cephea Early Feasibility Study
NCT: NCT05061004 · RECRUITING
NCT IDNCT05061004
StatusRECRUITING
Start Date2022-04-28
Completion2031-03-01
Brief Summary
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.
Frequently Asked Questions
What is Cephea Early Feasibility Study?
Cephea Early Feasibility Study is a clinical trial registered under NCT05061004. Current status: RECRUITING.
What is the status of NCT05061004?
The current status of NCT05061004 (Cephea Early Feasibility Study) is: RECRUITING.
When did Cephea Early Feasibility Study start?
Cephea Early Feasibility Study started on 2022-04-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.